Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEVANAC vs Vehicle for Macular Edema Prevention in Diabetic Retinopathy Cataract Surgery
NCT00782717Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Nov 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in macular edema comparing NEVANAC with Vehicle (2 arms). Primary endpoint: Percent of Patients Who Developed Macular Edema (ME) Within 90 Days Following Cataract Surgery. Started Nov 2008; status: completed.
02
Drugs
nepafenac
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT00782717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782717.